COVID-19: Vaccines and Therapeutics
As we get ready to mark World Immunization Week (April 24-30), it’s an appropriate time to celebrate the incredible gift of vaccines.
MAKING IT PLAIN: Rural Hospitals and the Healthcare Delivery System flyer.
Health care providers participating in the Centers for Disease Control and Prevention’s COVID-19 Vaccination Program must administer the vaccines at no cost to recipients, the Department of Health and Human Services’ Office of Inspector General reminded providers and the public.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices holds an emergency meeting on the Johnson & Johnson (Janssen) COVID-19 vaccine to review reports that six women aged 18-48 experienced a rare but serious condition involving blood clots and low…
The monoclonal antibody therapy REGEN-COV (casirivimab with imdevimab) reduced the risk of symptomatic COVID-19 in household contacts of people with SARS-CoV-2 by 81% in a phase 3 clinical trial conducted with the National Institute of Allergy and Infectious Diseases, Regeneron Pharmaceuticals…
The Food and Drug Administration and Centers for Disease Control and Prevention jointly recommended a pause in the use of Johnson & Johnson’s COVID-19 vaccine, following six reported cases of rare but severe types of blood clots following the vaccine’s administration.
Photo Credit: Penn Medicine
As Rush University Medical Center in Chicago ramped up COVID-19 vaccine distribution across the communities it serves, infectious disease experts looked for effective ways to connect with a key group: people who have reservations about taking the vaccine.
Pfizer said it is seeking an amended emergency use authorization for its COVID-19 vaccine, requesting that the Food and Drug Administration allow its use for individuals between 12 and 15 years old.